Effects of Stress Hyperglycemia on Acute Myocardial Infarction

Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes care 2003-11, Vol.26 (11), p.3129-3135
Hauptverfasser: Marfella, Raffaele, Siniscalchi, Mario, Esposito, Katherine, Sellitto, Ausilia, de Fanis, Umberto, Romano, Ciro, Portoghese, Michele, Siciliano, Silvio, Nappo, Francesco, Sasso, Ferdinando Carlo, Mininni, Nicola, Cacciapuoti, Federico, Lucivero, Giacomo, Giunta, Riccardo, Verza, Mario, Giugliano, Dario
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3135
container_issue 11
container_start_page 3129
container_title Diabetes care
container_volume 26
creator Marfella, Raffaele
Siniscalchi, Mario
Esposito, Katherine
Sellitto, Ausilia
de Fanis, Umberto
Romano, Ciro
Portoghese, Michele
Siciliano, Silvio
Nappo, Francesco
Sasso, Ferdinando Carlo
Mininni, Nicola
Cacciapuoti, Federico
Lucivero, Giacomo
Giunta, Riccardo
Verza, Mario
Giugliano, Dario
description Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1 , Michele Portoghese , MD 3 , Silvio Siciliano , MD 4 , Francesco Nappo , MD, PHD 1 , Ferdinando Carlo Sasso , MD, PHD 1 , Nicola Mininni , MD 4 , Federico Cacciapuoti , MD 1 , Giacomo Lucivero , MD, PHD 1 , Riccardo Giunta , MD 1 , Mario Verza , MD 1 and Dario Giugliano , MD, PHD 1 2 1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy 2 Cardiovascular Research Center, Second University of Naples, Naples, Italy 3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy 4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail: raffaele.marfella{at}unina2.it Abstract OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac outcome in patients with first MI. RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency ward. RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared with normoglycemic patients ( P < 0.001). CONCLUSIONS —During MI, hyperglycemia is associated with increased l
doi_str_mv 10.2337/diacare.26.11.3129
format Article
fullrecord <record><control><sourceid>highwire_cross</sourceid><recordid>TN_cdi_highwire_diabetes_diacare_26_11_3129</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>diacare_26_11_3129</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</originalsourceid><addsrcrecordid>eNptkEtPAjEUhRujEUT_gKvuzYy9fUzbjQkhICQYF-q6KX3AmIEh7Rgz_94hsHR1Fvece04-hB6BlJQx-exr62wKJa1KgJIB1VdoDJqJQgiurtGYANeF0JqO0F3O34QQzpW6RSPgQioqyBi9zGMMrsu4jfijSyFnvOyPIW2b3oV9bXF7wFP30wX81rdD29DZ4NUh2uS6uj3co5tomxweLjpBX4v552xZrN9fV7PpunCgOS90ZNQxTsB5AhG8H3ZUjGhBlJKOOMWpl0CkjFJqzjZRhQ1Y512wQgvt2QTR81-X2pxTiOaY6r1NvQFiTjDMBYahlQEwJxhD6Okc2tXb3W89HAfTJnQh_-f-A1H2YNA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</creator><creatorcontrib>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</creatorcontrib><description><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1 , Michele Portoghese , MD 3 , Silvio Siciliano , MD 4 , Francesco Nappo , MD, PHD 1 , Ferdinando Carlo Sasso , MD, PHD 1 , Nicola Mininni , MD 4 , Federico Cacciapuoti , MD 1 , Giacomo Lucivero , MD, PHD 1 , Riccardo Giunta , MD 1 , Mario Verza , MD 1 and Dario Giugliano , MD, PHD 1 2 1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy 2 Cardiovascular Research Center, Second University of Naples, Naples, Italy 3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy 4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail: raffaele.marfella{at}unina2.it Abstract OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac outcome in patients with first MI. RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency ward. RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared with normoglycemic patients ( P < 0.001). CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells, and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients. CRP, C-reactive protein ECG, electrocardiogram ET, ejection time ICT, isovolumetric contracting time IL-18, interleukin-18 IRT, isovolumetric relaxation time MI, myocardial infarction MPI, myocardial performance index Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted July 30, 2003. Received May 20, 2003. DIABETES CARE]]></description><identifier>ISSN: 0149-5992</identifier><identifier>EISSN: 1935-5548</identifier><identifier>DOI: 10.2337/diacare.26.11.3129</identifier><identifier>PMID: 14578250</identifier><language>eng</language><publisher>American Diabetes Association</publisher><ispartof>Diabetes care, 2003-11, Vol.26 (11), p.3129-3135</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</citedby><cites>FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Marfella, Raffaele</creatorcontrib><creatorcontrib>Siniscalchi, Mario</creatorcontrib><creatorcontrib>Esposito, Katherine</creatorcontrib><creatorcontrib>Sellitto, Ausilia</creatorcontrib><creatorcontrib>de Fanis, Umberto</creatorcontrib><creatorcontrib>Romano, Ciro</creatorcontrib><creatorcontrib>Portoghese, Michele</creatorcontrib><creatorcontrib>Siciliano, Silvio</creatorcontrib><creatorcontrib>Nappo, Francesco</creatorcontrib><creatorcontrib>Sasso, Ferdinando Carlo</creatorcontrib><creatorcontrib>Mininni, Nicola</creatorcontrib><creatorcontrib>Cacciapuoti, Federico</creatorcontrib><creatorcontrib>Lucivero, Giacomo</creatorcontrib><creatorcontrib>Giunta, Riccardo</creatorcontrib><creatorcontrib>Verza, Mario</creatorcontrib><creatorcontrib>Giugliano, Dario</creatorcontrib><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><title>Diabetes care</title><description><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1 , Michele Portoghese , MD 3 , Silvio Siciliano , MD 4 , Francesco Nappo , MD, PHD 1 , Ferdinando Carlo Sasso , MD, PHD 1 , Nicola Mininni , MD 4 , Federico Cacciapuoti , MD 1 , Giacomo Lucivero , MD, PHD 1 , Riccardo Giunta , MD 1 , Mario Verza , MD 1 and Dario Giugliano , MD, PHD 1 2 1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy 2 Cardiovascular Research Center, Second University of Naples, Naples, Italy 3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy 4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail: raffaele.marfella{at}unina2.it Abstract OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac outcome in patients with first MI. RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency ward. RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared with normoglycemic patients ( P < 0.001). CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells, and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients. CRP, C-reactive protein ECG, electrocardiogram ET, ejection time ICT, isovolumetric contracting time IL-18, interleukin-18 IRT, isovolumetric relaxation time MI, myocardial infarction MPI, myocardial performance index Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted July 30, 2003. Received May 20, 2003. DIABETES CARE]]></description><issn>0149-5992</issn><issn>1935-5548</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNptkEtPAjEUhRujEUT_gKvuzYy9fUzbjQkhICQYF-q6KX3AmIEh7Rgz_94hsHR1Fvece04-hB6BlJQx-exr62wKJa1KgJIB1VdoDJqJQgiurtGYANeF0JqO0F3O34QQzpW6RSPgQioqyBi9zGMMrsu4jfijSyFnvOyPIW2b3oV9bXF7wFP30wX81rdD29DZ4NUh2uS6uj3co5tomxweLjpBX4v552xZrN9fV7PpunCgOS90ZNQxTsB5AhG8H3ZUjGhBlJKOOMWpl0CkjFJqzjZRhQ1Y512wQgvt2QTR81-X2pxTiOaY6r1NvQFiTjDMBYahlQEwJxhD6Okc2tXb3W89HAfTJnQh_-f-A1H2YNA</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Marfella, Raffaele</creator><creator>Siniscalchi, Mario</creator><creator>Esposito, Katherine</creator><creator>Sellitto, Ausilia</creator><creator>de Fanis, Umberto</creator><creator>Romano, Ciro</creator><creator>Portoghese, Michele</creator><creator>Siciliano, Silvio</creator><creator>Nappo, Francesco</creator><creator>Sasso, Ferdinando Carlo</creator><creator>Mininni, Nicola</creator><creator>Cacciapuoti, Federico</creator><creator>Lucivero, Giacomo</creator><creator>Giunta, Riccardo</creator><creator>Verza, Mario</creator><creator>Giugliano, Dario</creator><general>American Diabetes Association</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20031101</creationdate><title>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</title><author>Marfella, Raffaele ; Siniscalchi, Mario ; Esposito, Katherine ; Sellitto, Ausilia ; de Fanis, Umberto ; Romano, Ciro ; Portoghese, Michele ; Siciliano, Silvio ; Nappo, Francesco ; Sasso, Ferdinando Carlo ; Mininni, Nicola ; Cacciapuoti, Federico ; Lucivero, Giacomo ; Giunta, Riccardo ; Verza, Mario ; Giugliano, Dario</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1944-9f32c3401cd01f1dd448630950887c0c842d71077f77943bf8eb1acdcea5959d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Marfella, Raffaele</creatorcontrib><creatorcontrib>Siniscalchi, Mario</creatorcontrib><creatorcontrib>Esposito, Katherine</creatorcontrib><creatorcontrib>Sellitto, Ausilia</creatorcontrib><creatorcontrib>de Fanis, Umberto</creatorcontrib><creatorcontrib>Romano, Ciro</creatorcontrib><creatorcontrib>Portoghese, Michele</creatorcontrib><creatorcontrib>Siciliano, Silvio</creatorcontrib><creatorcontrib>Nappo, Francesco</creatorcontrib><creatorcontrib>Sasso, Ferdinando Carlo</creatorcontrib><creatorcontrib>Mininni, Nicola</creatorcontrib><creatorcontrib>Cacciapuoti, Federico</creatorcontrib><creatorcontrib>Lucivero, Giacomo</creatorcontrib><creatorcontrib>Giunta, Riccardo</creatorcontrib><creatorcontrib>Verza, Mario</creatorcontrib><creatorcontrib>Giugliano, Dario</creatorcontrib><collection>CrossRef</collection><jtitle>Diabetes care</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Marfella, Raffaele</au><au>Siniscalchi, Mario</au><au>Esposito, Katherine</au><au>Sellitto, Ausilia</au><au>de Fanis, Umberto</au><au>Romano, Ciro</au><au>Portoghese, Michele</au><au>Siciliano, Silvio</au><au>Nappo, Francesco</au><au>Sasso, Ferdinando Carlo</au><au>Mininni, Nicola</au><au>Cacciapuoti, Federico</au><au>Lucivero, Giacomo</au><au>Giunta, Riccardo</au><au>Verza, Mario</au><au>Giugliano, Dario</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Stress Hyperglycemia on Acute Myocardial Infarction</atitle><jtitle>Diabetes care</jtitle><date>2003-11-01</date><risdate>2003</risdate><volume>26</volume><issue>11</issue><spage>3129</spage><epage>3135</epage><pages>3129-3135</pages><issn>0149-5992</issn><eissn>1935-5548</eissn><abstract><![CDATA[Effects of Stress Hyperglycemia on Acute Myocardial Infarction Role of inflammatory immune process in functional cardiac outcome Raffaele Marfella , MD, PHD 1 2 , Mario Siniscalchi , MD, PHD 1 , Katherine Esposito , MD 1 2 , Ausilia Sellitto , MD 1 , Umberto de Fanis , MD 1 , Ciro Romano , MD, PHD 1 , Michele Portoghese , MD 3 , Silvio Siciliano , MD 4 , Francesco Nappo , MD, PHD 1 , Ferdinando Carlo Sasso , MD, PHD 1 , Nicola Mininni , MD 4 , Federico Cacciapuoti , MD 1 , Giacomo Lucivero , MD, PHD 1 , Riccardo Giunta , MD 1 , Mario Verza , MD 1 and Dario Giugliano , MD, PHD 1 2 1 Department of Geriatric and Metabolic Diseases, Second University of Naples, Naples, Italy 2 Cardiovascular Research Center, Second University of Naples, Naples, Italy 3 Cardiac Surgery of “Monteverigine” Mercogliano Avellino, Italy 4 Cardiology Department of Hospital V. Monaldi Naples, Naples, Italy Address correspondence and reprint requests to Raffaele Marfella, MD, Via Emilio Scaglione, 141, 80145 Napoli, Italy. E-mail: raffaele.marfella{at}unina2.it Abstract OBJECTIVE —Stress hyperglycemia has been associated with increased mortality in patients with myocardial infarction (MI). We examined the association between plasma glucose levels, circulating inflammatory markers, T-cell activation, and functional cardiac outcome in patients with first MI. RESEARCH DESIGN AND METHODS —Echocardiographic parameters, circulating levels of interleukin-18 (IL-18), C-reactive protein (CPR), and the percent of CD16-CD56, CD4/CD8, CD152, and HLA-DR expression were investigated in 108 patients with acute MI on admission to the emergency ward. RESULTS —Our review found that 31 new hyperglycemic patients (glycemia ≥7 mmol/l) had higher infarct segment length ( P < 0.05) and myocardial performance index ( P < 0.02) and reduced transmitral Doppler flow ( P < 0.05), pulmonary flow analysis ( P < 0.02), and ejection fraction ( P < 0.05) compared with 36 hyperglycemic diabetic patients and 41 normoglycemic patients. Plasma IL-18 and CRP were higher in the hyperglycemic than in the normoglycemic patients ( P < 0.005), with the highest values in patients with new hyperglycemia ( P < 0.05). Hyperglycemic patients had a higher percent of CD16+/CD56+ cells and CD4/CD8 ratio ( P < 0.01), whereas they had lower CD152 expression (which has a negative regulatory function in T-cell activation) compared with normoglycemic patients ( P < 0.001). CONCLUSIONS —During MI, hyperglycemia is associated with increased levels of inflammatory markers, enhanced expression of cytotoxic T-cells, and reduced expression of T-cells, which are implicated in limiting the immune process. An increased inflammatory immune process seems a likely mechanism linking acute hyperglycemia to poor cardiac outcome in MI patients. CRP, C-reactive protein ECG, electrocardiogram ET, ejection time ICT, isovolumetric contracting time IL-18, interleukin-18 IRT, isovolumetric relaxation time MI, myocardial infarction MPI, myocardial performance index Footnotes A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Accepted July 30, 2003. Received May 20, 2003. DIABETES CARE]]></abstract><pub>American Diabetes Association</pub><pmid>14578250</pmid><doi>10.2337/diacare.26.11.3129</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0149-5992
ispartof Diabetes care, 2003-11, Vol.26 (11), p.3129-3135
issn 0149-5992
1935-5548
language eng
recordid cdi_highwire_diabetes_diacare_26_11_3129
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
title Effects of Stress Hyperglycemia on Acute Myocardial Infarction
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A03%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-highwire_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Stress%20Hyperglycemia%20on%20Acute%20Myocardial%20Infarction&rft.jtitle=Diabetes%20care&rft.au=Marfella,%20Raffaele&rft.date=2003-11-01&rft.volume=26&rft.issue=11&rft.spage=3129&rft.epage=3135&rft.pages=3129-3135&rft.issn=0149-5992&rft.eissn=1935-5548&rft_id=info:doi/10.2337/diacare.26.11.3129&rft_dat=%3Chighwire_cross%3Ediacare_26_11_3129%3C/highwire_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/14578250&rfr_iscdi=true